Brazil Veterinary Regenerative Medicine Market Size & Outlook

The veterinary regenerative medicine market in Brazil is expected to reach a projected revenue of US$ 158.6 million by 2033. A compound annual growth rate of 10.5% is expected of Brazil veterinary regenerative medicine market from 2026 to 2033.
Revenue, 2025 (US$M)
$72.6
Forecast, 2033 (US$M)
$158.6
CAGR, 2026 - 2033
10.5%
Report Coverage
Brazil

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Brazil veterinary regenerative medicine market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Related Markets

Brazil veterinary regenerative medicine market highlights

  • The Brazil veterinary regenerative medicine market generated a revenue of USD 72.6 million in 2025 and is expected to reach USD 158.6 million by 2033.
  • The Brazil market is expected to grow at a CAGR of 10.5% from 2026 to 2033.
  • In terms of segment, stem cells was the largest revenue generating product in 2025.
  • Other Products is the most lucrative product segment registering the fastest growth during the forecast period.


Veterinary regenerative medicine market data book summary

Market revenue in 2025USD 72.6 million
Market revenue in 2033USD 158.6 million
Growth rate10.5% (CAGR from 2026 to 2033)
Largest segmentStem cells
Fastest growing segmentOther Products
Historical data2021 - 2024
Base year2025
Forecast period2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationStem cells, Platelet-Rich Plasma (PRP), Other Products
Key market players worldwideBoehringer Ingelheim, Zoetis Inc Class A, Dechra Pharmaceuticals, Integra Lifesciences Holdings Corp, Ardent Health Services, Vetherapy, VET-STEM INC., Enso Discoveries, Animal Cell Therapies


Other key industry trends

  • In terms of revenue, Brazil accounted for 5.0% of the global veterinary regenerative medicine market in 2025.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Latin America, Brazil veterinary regenerative medicine market is projected to lead the regional market in terms of revenue in 2033.
  • Argentina is the fastest growing regional market in Latin America and is projected to reach USD 60.5 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Veterinary Regenerative Medicine Market Companies

Name Profile # Employees HQ Website
Animal Cell Therapies View profile 1-10 San Diego, California, United States, North America http://actcells.com
Enso Discoveries View profile 1-10 Manhattan, Kansas, United States, North America https://www.ensodiscoveries.com
VET-STEM INC. View profile - Poway, California, United States, North America https://vetstem.com/
Vetherapy View profile 1-10 Coimbrã, Leiria, Portugal, Europe https://www.vetherapy.co/
Ardent Health Services View profile 10001+ Nashville, Tennessee, United States, North America http://ardenthealth.com
Dechra Pharmaceuticals View profile 501-1000 Northwich, Cheshire, United Kingdom, Europe http://www.dechra.com
Boehringer Ingelheim View profile 10001+ Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe https://www.boehringer-ingelheim.com/
Integra Lifesciences Holdings Corp View profile 3946 1100 Campus Road, Princeton, NJ, United States, 08540 https://www.integralife.com
Zoetis Inc Class A View profile 14100 10 Sylvan Way, Parsippany, NJ, United States, 07054 https://www.zoetis.com

Brazil veterinary regenerative medicine market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary regenerative medicine market will help companies and investors design strategic landscapes.


Stem cells was the largest segment with a revenue share of 60.74% in 2025. Horizon Databook has segmented the Brazil veterinary regenerative medicine market based on stem cells, platelet-rich plasma (prp), other products covering the revenue growth of each sub-segment from 2021 to 2033.


In August 2022, Ourofino Sade Animal anticipates increasing investments in the pet market to increase revenue, according to a GlobalPETS article. NeoStem is intended to help dogs with disorders such as osteoarthritis, conjunctivitis sicca, and distemper sequelae.

To preserve the quality of the cells, they are taken from young animals up to 2 years old. The Brazilian Federal Council of Veterinary Medicine regulated the use of stem cells in animals in 2021. The Brazilian company expects to widely promote this treatment throughout Latin America in the upcoming years.

Reasons to subscribe to Brazil veterinary regenerative medicine market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Brazil veterinary regenerative medicine market databook

  • Our clientele includes a mix of veterinary regenerative medicine market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Brazil veterinary regenerative medicine market , including forecasts for subscribers. This country databook contains high-level insights into Brazil veterinary regenerative medicine market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Brazil Product - Veterinary Regenerative Medicine Market size, 2025 - 2033 (US$M)

Brazil Veterinary Regenerative Medicine Market Outlook Share, 2025 & 2033 (US$M)

Brazil Product - Veterinary Regenerative Medicine Market size, 2025 - 2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online